Abstract

BackgroundRecent studies suggest an association between Lipoprotein(a) [Lp(a)] and the development of diabetes mellitus. We analyzed the association between baseline Lp(a) levels and diabetes development after 4 years of follow-up, in a population of apparently healthy Korean subjects.MethodsA total of 2,536 non-diabetic participants (mean age: 41 years, men: 92%) of a health checkup program were included in the study. Diabetes development was defined by fasting blood glucose ≥126 mg/dL, HbA1c ≥6.5%, and self-reported treatment of diabetes. Homeostasis model assessment (HOMA) indices were used to assess insulin resistance (IR) and insulin secretion (IS). Presence of IR and impaired IS was defined by being in the highest quartile of HOMA-IR and in the lowest quartile HOMA-IS.ResultsAfter four years, 3.4% of the participants developed diabetes. The odds ratio (OR) of developing diabetes was lowest in the 4th quartile group of baseline Lp(a) (0.323 [95% CI 0.153–0.685])with the 1st quartile group as the reference. The subjects with both IR & impaired IS plus baseline Lp(a)<50 mg/dL showed the higher OR for diabetes development compared with those without IR and normal IS as the reference (67.277 [20.218–223.871], and those with IR plus Lp(a)<50 mg/dL showed higher OR for diabetes than in those with impaired IS and Lp(a)<50 mg/dL (3.811 [1.938–7.495] vs. 3.452 [1.620–7.353]).ConclusionsThe subjects with low baseline Lp(a) level showed higher risk for development of diabetes compared with high baseline Lp(a) level, and this was prominent in those with IR than in those with impaired IS.

Highlights

  • Lipoprotein(a) [Lp(a)] is produced mainly by the liver and is a low-density lipoprotein (LDL)like particle, consisting of a apolipoprotein(a) moiety covalently attached to one molecule of apoB100 via a disulfide bond [1]

  • The odds ratio (OR) of developing diabetes was lowest in the 4th quartile group of baseline Lp(a) (0.323 [95% confidence intervals (CI) 0.153– 0.685])with the 1st quartile group as the reference

  • The subjects with both insulin resistance (IR) & impaired insulin secretion (IS) plus baseline Lp(a)

Read more

Summary

Introduction

Lipoprotein(a) [Lp(a)] is produced mainly by the liver and is a low-density lipoprotein (LDL)like particle, consisting of a apolipoprotein(a) moiety covalently attached to one molecule of apoB100 via a disulfide bond [1]. High serum level of Lp(a) is known to be associated with increased risk of cardiovascular disease (CVD) [2]. Recent studies suggest the association between hyperlipidemia and diabetes development. High intracellular concentration of cholesterol is known to affect insulin secretory process, and hypercholesterolemia impairs insulin secretion in LDL receptor knockout mice [5,6]. In a human study, increased serum level of total cholesterol (TC) was related with decreased insulin secretory function assessed by homeostasis model assessment (HOMA) for beta cell [7]. Risk of development of type 2 diabetes is reported to significantly increase as the ratio of TC to high-density lipoprotein cholesterol (HDL-C) increases [8]. Recent studies suggest an association between Lipoprotein(a) [Lp(a)] and the development of diabetes mellitus. We analyzed the association between baseline Lp(a) levels and diabetes development after 4 years of follow-up, in a population of apparently healthy Korean subjects

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call